SUSTAINABLE DEVELOPMENT
Innovate. Sustain. Transform.
Save up to 30% on top Physical Sciences & Engineering titles!
Side Effects of Drugs Annual
A Worldwide Yearly Survey of New Data and Trends in Adverse Drug Reactions
- 1st Edition, Volume 30 - July 3, 2008
- Editor: Jeffrey K. Aronson
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 4 - 5 2 7 6 7 - 7
- eBook ISBN:9 7 8 - 0 - 0 8 - 0 9 3 1 5 1 - 7
The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then, as a yearly update to the voluminous encyclopedia Meyler's Side Effe… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteThe Side Effects of Drugs Annual was first published in 1977. It has been continually published since then, as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has contributed to the informative, by critically interpreting it, and by pointing to whatever is misleading.
- Provides a critical yearly survey of new data and trends in the side effects of drugs
- Each drug article contains case histories
- Contains detailed information on drug-drug interactions
Pharmacologists, clinicians, pharmaceutical companies, clinical toxicologists, clinical pharmacologists and medical libraries
- No. of pages: 672
- Language: English
- Edition: 1
- Volume: 30
- Published: July 3, 2008
- Imprint: Elsevier Science
- Hardback ISBN: 9780444527677
- eBook ISBN: 9780080931517
JA
Jeffrey K. Aronson
Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK’s National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.
Affiliations and expertise
consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals TrustRead Side Effects of Drugs Annual on ScienceDirect